BR0207058A - Método para reduzir doença associada com transfusão e efeitos adversos no plasma para aumentar a pureza e segurança de múltiplos componentes derivados de sangue, crioprecipitado enriquecido, plasma crio-exaurido, e, cola de fibrina - Google Patents

Método para reduzir doença associada com transfusão e efeitos adversos no plasma para aumentar a pureza e segurança de múltiplos componentes derivados de sangue, crioprecipitado enriquecido, plasma crio-exaurido, e, cola de fibrina

Info

Publication number
BR0207058A
BR0207058A BR0207058-8A BR0207058A BR0207058A BR 0207058 A BR0207058 A BR 0207058A BR 0207058 A BR0207058 A BR 0207058A BR 0207058 A BR0207058 A BR 0207058A
Authority
BR
Brazil
Prior art keywords
plasma
safety
blood
purity
adverse effects
Prior art date
Application number
BR0207058-8A
Other languages
English (en)
Portuguese (pt)
Inventor
Edward Shanbrom
Original Assignee
Shanbrom Tech Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US09/778,681 external-priority patent/US6541518B2/en
Application filed by Shanbrom Tech Llc filed Critical Shanbrom Tech Llc
Publication of BR0207058A publication Critical patent/BR0207058A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N1/00—Preservation of bodies of humans or animals, or parts thereof
    • A01N1/02—Preservation of living parts
    • A01N1/0205—Chemical aspects
    • A01N1/021—Preservation or perfusion media, liquids, solids or gases used in the preservation of cells, tissue, organs or bodily fluids
    • A01N1/0215—Disinfecting agents, e.g. antimicrobials for preserving living parts
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N37/00—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom having three bonds to hetero atoms with at the most two bonds to halogen, e.g. carboxylic acids
    • A01N37/36—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom having three bonds to hetero atoms with at the most two bonds to halogen, e.g. carboxylic acids containing at least one carboxylic group or a thio analogue, or a derivative thereof, and a singly bound oxygen or sulfur atom attached to the same carbon skeleton, this oxygen or sulfur atom not being a member of a carboxylic group or of a thio analogue, or of a derivative thereof, e.g. hydroxy-carboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14—Blood; Artificial blood
    • A61K35/16—Blood plasma; Blood serum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
    • A61L2/0005—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts
    • A61L2/0011—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts using physical methods
    • A61L2/0023—Heat
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
    • A61L2/0005—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts
    • A61L2/0082—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts using chemical substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Zoology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Wood Science & Technology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Environmental Sciences (AREA)
  • Cell Biology (AREA)
  • Molecular Biology (AREA)
  • Dentistry (AREA)
  • Communicable Diseases (AREA)
  • Pest Control & Pesticides (AREA)
  • Plant Pathology (AREA)
  • Agronomy & Crop Science (AREA)
  • Oncology (AREA)
  • Biotechnology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
BR0207058-8A 2001-02-07 2002-02-07 Método para reduzir doença associada com transfusão e efeitos adversos no plasma para aumentar a pureza e segurança de múltiplos componentes derivados de sangue, crioprecipitado enriquecido, plasma crio-exaurido, e, cola de fibrina BR0207058A (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US09/778,681 US6541518B2 (en) 2000-10-23 2001-02-07 Enhanced production of safe plasma preparations
US27849601P 2001-03-23 2001-03-23
PCT/US2002/003996 WO2002087560A1 (en) 2001-02-07 2002-02-07 Carboxylic acid such as citric acid for desinfecting or enhacing the production of blood products such as plasma, cryoprecipitate or/and platelet

Publications (1)

Publication Number Publication Date
BR0207058A true BR0207058A (pt) 2004-02-17

Family

ID=26959126

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0207058-8A BR0207058A (pt) 2001-02-07 2002-02-07 Método para reduzir doença associada com transfusão e efeitos adversos no plasma para aumentar a pureza e segurança de múltiplos componentes derivados de sangue, crioprecipitado enriquecido, plasma crio-exaurido, e, cola de fibrina

Country Status (6)

Country Link
EP (1) EP1363616A1 (es)
AU (1) AU2002248415B8 (es)
BR (1) BR0207058A (es)
CA (1) CA2438223A1 (es)
MX (1) MXPA03007069A (es)
WO (1) WO2002087560A1 (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060019234A1 (en) * 2004-07-22 2006-01-26 Shanbrom Technologies, Llc Modern blood banking employing improved cell preservation composition
US20070049732A1 (en) * 2005-09-01 2007-03-01 Zurlo Eugene J Ultra-high yield intravenous immune globulin preparation
US8835104B2 (en) 2007-12-20 2014-09-16 Fenwal, Inc. Medium and methods for the storage of platelets
EP3662750A1 (en) 2011-04-07 2020-06-10 Fenwal, Inc. Automated methods and systems for providing platelet concentrates with reduced residual plasma volumes and storage media for such platelet concentrates
WO2017136785A1 (en) 2016-02-03 2017-08-10 Plasma Technologies, Llc Methods for extracting proteins from a blood-based material
CN115990296A (zh) 2017-09-22 2023-04-21 贝克顿·迪金森公司 用作导管封管液的4%柠檬酸三钠溶液
US10815270B1 (en) 2019-09-20 2020-10-27 Plasma Technologies, Llc Compositions and methods for high efficiency protein precipitation

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3803115A (en) * 1972-05-17 1974-04-09 Baxter Laboratories Inc Stabilization of ahf using heparin
US4105650A (en) * 1975-04-11 1978-08-08 Edward Shanbrom, Inc. Method of preserving blood plasma i
JPS56135418A (en) * 1980-03-27 1981-10-22 Green Cross Corp:The Heat treatment of aqueous solution containing 8 factor of coagulation of blood derived from human
US4305871A (en) * 1980-09-02 1981-12-15 Edward Shanbrom Method of selectively increasing yield and purity of certain cryoprecipitate proteins by heating
US4850993A (en) * 1986-12-22 1989-07-25 Miles Laboratories, Inc. Blood bag system incorporating quinolone carboxylic, acid derivatives
US4977246A (en) * 1989-06-06 1990-12-11 Rorer Pharmaceutical Corporation High recovery process for antihemophilic factor
US4925665A (en) * 1989-06-22 1990-05-15 Thomas Jefferson University Glucose free primary anticoagulant for blood containing citrate ions
US5370869A (en) * 1990-09-04 1994-12-06 Shanbrom; Edward Antimicrobial preservation of platelets and blood factors
US5196428A (en) * 1992-04-03 1993-03-23 Bristol-Myers Squibb Company Imidazo[4,5-b]qinolinyl oxy alkyl ureas
EP0614368A1 (en) * 1992-05-04 1994-09-14 Edward Shanbrom Safe human transfusion blood
EP0744892B1 (en) * 1994-12-16 2003-12-03 Baxter International Inc. Anticoagulant compositions for platelets
US6037116A (en) * 1996-06-14 2000-03-14 Biostore New Zealand, Ltd. Compositions comprising betaine, sodium citrate and sodium chloride and methods for the preservation of biological materials

Also Published As

Publication number Publication date
WO2002087560A1 (en) 2002-11-07
AU2002248415B2 (en) 2008-03-20
EP1363616A1 (en) 2003-11-26
CA2438223A1 (en) 2002-11-07
MXPA03007069A (es) 2004-10-15
AU2002248415B8 (en) 2008-07-24

Similar Documents

Publication Publication Date Title
BRPI0504445A (pt) composição de trombina e processo para a sua preparação
CA2034489A1 (en) Methods for the inactivation of viruses in viral-contaminated pharmaceutical compositions
BR0113710A (pt) Compostos, processo para a preparação e utilização dos mesmos, composição farmacêutica, processo para o tratamento e profilaxia de artrite, enfermidades cardiovasculares, diabetes, insuficiência renal, distúrbios alimentares e obesidade
HUP9700603A1 (hu) Gyógyászati készítmény véralvadási zavarok kezelésére
BR9915553A (pt) Amidas de ácido antranìlico e seu emprego como medicamento
IL112572A0 (en) Dexanabinol derivatives and their use as nmda blocking pharmaceutical compositions
AU2001289438A1 (en) Pharmaceutical semi-solid composition of isotretinoin
BR9712523A (pt) Novos derivados de pirazol heterociclilmetil-substituìdos
BR9811260A (pt) Pequenas moléculas úteis no tratamento de doença inflamatória
BR9916678A (pt) Inibidores de trombina
WO2004007743A3 (en) Use of cpg nucleic acids in prion-disease
WO2002047668A3 (de) Neue arzneimittelkompositionen auf der basis von anticholinergika und ciclesonide
DE68929388D1 (de) Aus Harn isolierte antikoagulierende Verbindung
BR0207058A (pt) Método para reduzir doença associada com transfusão e efeitos adversos no plasma para aumentar a pureza e segurança de múltiplos componentes derivados de sangue, crioprecipitado enriquecido, plasma crio-exaurido, e, cola de fibrina
BR9907025A (pt) Polissacarìdeos sintéticos, processo para sua preparação e composições farmacêuticas que contêm os mesmos
BR0007448A (pt) Uso de um inibidor de trombina de baixo peso molecular, solução de diálise, concentrado de diálise, kit de partes para uso em diálise, processo para a preparação de uma solução, ou de um concentrado, e, método de tratamento por diálise de um paciente necessitando de tal tratamento
WO2005027821A3 (en) Large scale preparation of alpha-1 proteinase inhibitor and use thereof
WO2003047507A3 (en) Factor viii c2 domain variants
AU2850292A (en) A process for the production of a virus-free concentrate of thrombin
NO993407L (no) Fremstilling av proteinpreparater med nedsatt aggregatinnhold
BR0107701A (pt) Produtos alimentìcios e processos
BR9705456A (pt) Compostos heterocìclicos, processo de aminometila para sua preparação e composições farmacêuticas que os contêm.
DE69636527D1 (de) Antigenes protein aus malassezia
AR046969A1 (es) Composicion enteral para la cicatrizacion de heridas
WO2003059286A3 (en) Methods and compositions for oxygen transport comprising modified hemoglobin in plasma

Legal Events

Date Code Title Description
B08F Application fees: dismissal - article 86 of industrial property law

Free format text: REFERENTE A 7A, 8A E 9A ANUIDADE(S).

B08K Lapse as no evidence of payment of the annual fee has been furnished to inpi (acc. art. 87)

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2094 DE 22/02/2011.